Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, pu… Read more
Bio-Rad Laboratories Inc (BIO) - Total Liabilities
Latest total liabilities as of December 2025: $3.12 Billion USD
Based on the latest financial reports, Bio-Rad Laboratories Inc (BIO) has total liabilities worth $3.12 Billion USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bio-Rad Laboratories Inc - Total Liabilities Trend (1985–2025)
This chart illustrates how Bio-Rad Laboratories Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bio-Rad Laboratories Inc Competitors by Total Liabilities
The table below lists competitors of Bio-Rad Laboratories Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Glaukos Corp
NYSE:GKOS
|
USA | $229.84 Million |
|
Global Unichip Corp
TW:3443
|
Taiwan | NT$15.53 Billion |
|
Mirvac Group
PINK:MRVGF
|
USA | $5.30 Billion |
|
Galp Energia SGPS S.A
OTCGREY:GLPEF
|
USA | $10.40 Billion |
|
SCREEN Holdings Co. Ltd
OTCGREY:DINRF
|
USA | $250.59 Billion |
|
Xinyi Glass Holdings Ltd
PINK:XYIGY
|
USA | $11.99 Billion |
|
SSR Mining Inc
NASDAQ:SSRM
|
USA | $1.76 Billion |
|
Campbell’s Co
NYSE:CPB
|
USA | $10.99 Billion |
Liability Composition Analysis (1985–2025)
This chart breaks down Bio-Rad Laboratories Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.62 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 1.02 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bio-Rad Laboratories Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bio-Rad Laboratories Inc (1985–2025)
The table below shows the annual total liabilities of Bio-Rad Laboratories Inc from 1985 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $3.12 Billion | +11.74% |
| 2024-12-31 | $2.79 Billion | -21.45% |
| 2023-12-31 | $3.56 Billion | -8.45% |
| 2022-12-31 | $3.89 Billion | -5.54% |
| 2021-12-31 | $4.11 Billion | +33.03% |
| 2020-12-31 | $3.09 Billion | +37.22% |
| 2019-12-31 | $2.25 Billion | +41.68% |
| 2018-12-31 | $1.59 Billion | +18.47% |
| 2017-12-31 | $1.34 Billion | +5.62% |
| 2016-12-31 | $1.27 Billion | +4.28% |
| 2015-12-31 | $1.22 Billion | +5.46% |
| 2014-12-31 | $1.16 Billion | -3.82% |
| 2013-12-31 | $1.20 Billion | -15.82% |
| 2012-12-31 | $1.43 Billion | +5.59% |
| 2011-12-31 | $1.35 Billion | -11.16% |
| 2010-12-31 | $1.52 Billion | +21.14% |
| 2009-12-31 | $1.26 Billion | +30.00% |
| 2008-12-31 | $966.62 Million | -3.33% |
| 2007-12-31 | $999.90 Million | +28.75% |
| 2006-12-31 | $776.63 Million | +1.04% |
| 2005-12-31 | $768.61 Million | -0.79% |
| 2004-12-31 | $774.73 Million | +55.95% |
| 2003-12-31 | $496.79 Million | +47.15% |
| 2002-12-31 | $337.62 Million | -15.63% |
| 2001-12-31 | $400.15 Million | -0.38% |
| 2000-12-31 | $401.66 Million | -10.50% |
| 1999-12-31 | $448.80 Million | +193.33% |
| 1998-12-31 | $153.00 Million | -1.42% |
| 1997-12-31 | $155.20 Million | +53.06% |
| 1996-12-31 | $101.40 Million | -20.78% |
| 1995-12-31 | $128.00 Million | -4.41% |
| 1994-12-31 | $133.90 Million | -10.49% |
| 1993-12-31 | $149.60 Million | -9.66% |
| 1992-12-31 | $165.60 Million | +2.03% |
| 1991-12-31 | $162.30 Million | +22.86% |
| 1990-12-31 | $132.10 Million | +14.37% |
| 1989-12-31 | $115.50 Million | +20.56% |
| 1988-12-31 | $95.80 Million | +16.97% |
| 1987-12-31 | $81.90 Million | +40.48% |
| 1986-12-31 | $58.30 Million | +40.14% |
| 1985-12-31 | $41.60 Million | -- |